# Codex Review: xgjk_fullflow_5_subjects

Date: 2026-06-29
Hermes output: `runs/hermes_xgjk_fullflow_5_subjects.md`

## Verdict

Pass with Codex revisions.

Hermes' independent review was useful for prioritizing the business risks, especially rule-version ambiguity, zero-opinion pass-through, post-monitor AI waiting opacity, and expert inbox non-receipt. Codex did not adopt Hermes' inferred internal root cause as a confirmed fact. The final Markdown phrases this as a user-visible workflow stall and rules-verification risk, not as a proven implementation failure.

## Boundary Check

- Hermes read the allowed context, spec copy, rule excerpt, Codex evidence JSONs, and prior Markdown opinion.
- Hermes wrote the requested output file: `runs/hermes_xgjk_fullflow_5_subjects.md`.
- Codex inspected `runs/hermes_xgjk_fullflow_5_subjects_stdout.txt`; no evidence of remote login, credential use, source-code edits, or unauthorized production writes was found.

## Codex Verification

- Codex actually operated the remote test system and created/submitted five 31-center test subjects.
- Latest PM and expert read-only poll was saved at `output/xgjk_system_audit_20260629/fullflow5/notes/poll_latest_pm_experts.json`.
- Latest screenshots were saved under `output/xgjk_system_audit_20260629/fullflow5/screenshots/latest-*.png`.
- Latest user-visible state:
  - all five UAT subjects remained `AI审核中`;
  - PM AI report showed 6 subjects and 0 completed AI reviews;
  - both medical expert inboxes showed no pending final review.
- Final business/process Markdown was rewritten at `output/xgjk_system_audit_20260629/玄关入排审核系统多角色流程审阅意见.md`.
- Final Markdown QC:
  - five role chapters present;
  - no account numbers, passwords, code/API/security wording, or debug/log wording found by text scan;
  - monitor finding corrected from "no state advance" to "advanced to AI审核中 but progress/closure remained opaque".

## Hermes Output Review

- Adopted:
  - strengthen PM rule-version and launch-gate findings;
  - quantify the 5/5 subjects stuck in `AI审核中` and 0 completed AI reviews;
  - strengthen supervisor/monitor structured-pass confirmation because 10/10 approvals had blank free-text opinions;
  - add both-expert non-receipt to the medical expert chapter;
  - preserve evidence limits and future validation needs.
- Revised:
  - avoided stating that non-structured rules definitely caused the AI review stall;
  - avoided technical terms in the final company-facing Markdown;
  - removed implementation-level framing and kept the report in clinical operations/workflow language.

## Residual Risk

- The exact internal reason for the five subjects staying in `AI审核中` remains unverified.
- Rejection, supplement, resubmission, completed AI review, and dual-expert final review were not exercised because the five tested subjects did not reach expert final review.
- The report should be treated as a process UAT opinion, not a completed validation of the whole system.
